484 results
Keyword Docetaxel Hikma Remove keyword
-
List item
Human medicine European public assessment report (EPAR): Kanjinti
trastuzumab, Stomach Neoplasms; Breast Neoplasms
Date of authorisation: 16/05/2018,
, Revision: 10, Authorised, Last updated: 24/03/2023
medicines: with paclitaxel or docetaxel, or with another class of … medicines: with paclitaxel or docetaxel, or with another class of … -
List item
Human medicine European public assessment report (EPAR): Trazimera
trastuzumab, Stomach Neoplasms; Breast Neoplasms
Date of authorisation: 26/07/2018,
, , Revision: 11, Authorised, Last updated: 17/10/2022
medicines: with paclitaxel or docetaxel, or with another class of … medicines: with paclitaxel or docetaxel, or with another class of … -
List item
Human medicine European public assessment report (EPAR): Herceptin
trastuzumab, Stomach Neoplasms; Breast Neoplasms
Date of authorisation: 28/08/2000, Revision: 42, Authorised, Last updated: 17/03/2023medicines: with paclitaxel or docetaxel, or with an aromatase inhibitor … combination with paclitaxel or docetaxel in a total of 657 patients … combination with paclitaxel or docetaxel, around half of the patients … -
List item
Human medicine European public assessment report (EPAR): Perjeta
pertuzumab, Breast Neoplasms
Date of authorisation: 04/03/2013, Revision: 22, Authorised, Last updated: 29/08/2023used with trastuzumab and docetaxel (other cancer medicines … medicines (trastuzumab and docetaxel). Patients were treated until … Perjeta plus trastuzumab and docetaxel responded to treatment, compared … -
List item
Human medicine European public assessment report (EPAR): Jevtana
cabazitaxel, Prostatic Neoplasms
Date of authorisation: 17/03/2011, Revision: 23, Authorised, Last updated: 06/07/2023previously been treated with docetaxel (another cancer medicine … previously been treated with docetaxel. The effects of Jevtana were … previously been treated with docetaxel (another cancer medicine … -
List item
Human medicine European public assessment report (EPAR): Zytiga
abiraterone acetate, Prostatic Neoplasms
Date of authorisation: 05/09/2011,
, Revision: 26, Authorised, Last updated: 06/12/2022
and chemotherapy containing docetaxel have not worked or no longer … treatment and chemotherapy with docetaxel, the main measure of effectiveness … and chemotherapy containing docetaxel have not worked or no longer … -
List item
Human medicine European public assessment report (EPAR): Xeloda
capecitabine, Colonic Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Stomach Neoplasms
Date of authorisation: 02/02/2001, Revision: 30, Authorised, Last updated: 26/10/2022body). Xeloda is used with docetaxel (another cancer medicine … -
List item
Human medicine European public assessment report (EPAR): Ontruzant
trastuzumab, Stomach Neoplasms; Breast Neoplasms
Date of authorisation: 15/11/2017,, Revision: 14, Authorised, Last updated: 20/09/2022
medicines: with paclitaxel or docetaxel, or with another class of … medicines: with paclitaxel or docetaxel, or with another class of … -
List item
Human medicine European public assessment report (EPAR): Nubeqa
darolutamide, Prostatic Neoplasms, Castration-Resistant
Date of authorisation: 27/03/2020,, Revision: 4, Authorised, Last updated: 20/03/2023
used in combination with docetaxel (another cancer medicine … were given together with docetaxel and androgen deprivation … Nubeqa given together with docetaxel are rash and hypertension … -
List item
Human medicine European public assessment report (EPAR): Herzuma (updated)
trastuzumab, Stomach Neoplasms; Breast Neoplasms
Date of authorisation: 09/02/2018,, Revision: 20, Authorised, Last updated: 20/09/2023
medicines: with paclitaxel or docetaxel, or with another class of … medicines: with paclitaxel or docetaxel, or with another class of … -
List item
Human medicine European public assessment report (EPAR): Abiraterone Krka
abiraterone acetate, Prostatic Neoplasms
Date of authorisation: 24/06/2021,
, Revision: 2, Authorised, Last updated: 08/03/2023
and chemotherapy containing docetaxel have not worked or no longer … and chemotherapy containing docetaxel have not worked or no longer … -
List item
Human medicine European public assessment report (EPAR): Cyramza
Ramucirumab, Stomach Neoplasms
Date of authorisation: 19/12/2014, Revision: 15, Authorised, Last updated: 13/12/2022treated with Cyramza and docetaxel lived longer than patients … longer than patients receiving docetaxel and placebo: on average 10.5 … Cyramza in combination with docetaxel is indicated for the treatment … -
List item
Human medicine European public assessment report (EPAR): Xtandi
enzalutamide, Prostatic Neoplasms
Date of authorisation: 21/06/2013,
Date of refusal: 26/04/2013, Revision: 21, Authorised, Last updated: 17/06/2022when either: treatment with docetaxel (a cancer medicine) has not … either: • treatment with docetaxel (a cancer medicine) has not … were previously treated with docetaxel. In this study, Xtandi was … -
List item
Summary of opinion: Herwenda (new)
trastuzumab, opinion date: 14/09/2023, Positive, Last updated: 15/09/2023suitable. in combination with docetaxel for the treatment of those … in combination with docetaxel for the treatment of those … combination with paclitaxel or docetaxel. - in combination with … -
List item
Human medicine European public assessment report (EPAR): Iressa
gefitinib, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 24/06/2009, Revision: 16, Authorised, Last updated: 17/07/2023Iressa was compared with docetaxel (another anticancer medicine … similar to those who took docetaxel. What is the risk associated … Iressa was compared with docetaxel (another anticancer medicine … -
List item
Human medicine European public assessment report (EPAR): Cabazitaxel Accord
cabazitaxel, Prostatic Neoplasms, Castration-Resistant
Date of authorisation: 28/08/2020,, Revision: 5, Authorised, Last updated: 27/07/2023
previously been treated with docetaxel (another cancer medicine … previously treated with a docetaxel-containing regimen (see section 5.1 … -
List item
Human medicine European public assessment report (EPAR): Capecitabine Accord
capecitabine, Colonic Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Stomach Neoplasms
Date of authorisation: 20/04/2012,, Revision: 16, Authorised, Last updated: 03/08/2023
Capecitabine Accord is used with docetaxel (another cancer medicine … -
List item
Human medicine European public assessment report (EPAR): Capecitabine Medac
capecitabine, Colorectal Neoplasms
Date of authorisation: 19/11/2012,, Revision: 13, Authorised, Last updated: 31/03/2023
Capecitabine medac is used with docetaxel (another cancer medicine … -
List item
Human medicine European public assessment report (EPAR): Capecitabine Teva
capecitabine, Colonic Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Stomach Neoplasms
Date of authorisation: 20/04/2012,, Revision: 15, Authorised, Last updated: 08/09/2021
Capecitabine Teva is used with docetaxel (another cancer medicine … -
List item
Human medicine European public assessment report (EPAR): Tecentriq
atezolizumab, Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung; Urologic Neoplasms; Breast Neoplasms; Small Cell Lung Carcinoma
Date of authorisation: 20/09/2017, Revision: 22, Authorised, Last updated: 25/07/2023Tecentriq is more effective than docetaxel (another cancer medicine … average while those given docetaxel lived for 10 months. In a … 10 months for patients on docetaxel. In another main study of … -
List item
Human medicine European public assessment report (EPAR): Lumykras
sotorasib, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 06/01/2022,, 
, Revision: 1, Authorised, Last updated: 29/11/2022
another cancer medicine, docetaxel. What measures are being taken … another cancer medicine, docetaxel. What measures are being … -
List item
Human medicine European public assessment report (EPAR): Opdivo (updated)
nivolumab, Melanoma; Hodgkin Disease; Carcinoma, Renal Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Squamous Cell Carcinoma of Head and Neck; Urologic Neoplasms; Mesothelioma; Colorectal Neoplasms
Date of authorisation: 19/06/2015, Revision: 55, Authorised, Last updated: 08/09/2023compared with 9.4 months with docetaxel (another cancer medicine … months in patients given docetaxel. Supportive information from … compared with 9.4 months with docetaxel (another cancer medicine … -
List item
Human medicine European public assessment report (EPAR): Capecitabine SUN
capecitabine, Stomach Neoplasms; Breast Neoplasms; Colonic Neoplasms; Colorectal Neoplasms
Date of authorisation: 21/06/2013,, Revision: 3, Withdrawn, Last updated: 22/12/2016
Capecitabine in combination with docetaxel is indicated for the treatment … regimen. - in combination with docetaxel for the treatment of patients … Capecitabine SUN is used with docetaxel (another anticancer medicine … -
List item
Human medicine European public assessment report (EPAR): Abiraterone Accord (updated)
abiraterone acetate, Prostatic Neoplasms
Date of authorisation: 26/04/2021,, Revision: 1, Authorised, Last updated: 25/09/2023
and chemotherapy containing docetaxel have not worked or no longer … and chemotherapy containing docetaxel have not worked or no longer … -
List item
Human medicine European public assessment report (EPAR): Abiraterone Mylan (updated)
abiraterone acetate, Prostatic Neoplasms
Date of authorisation: 20/08/2021,, Revision: 4, Authorised, Last updated: 11/09/2023
and chemotherapy containing docetaxel have not worked or no longer … and chemotherapy containing docetaxel have not worked or no longer …